REFERENCES
- AstraZeneca Pharmaceuticals L P. Seroquel (quetiapine fumarate) product information and medication guide. October, 2006, (30417-00 Rev. 10/06 244365)
- Baptista T., Kim N., Beulieu S., deBaptista E. Obesity and related metabolic abnormalities during drug administration: Mechanisms, management, and research perspectives. Pharmacopsychiatry 2002; 35(6)205–219
- Calabrese J., Keck P., Macfadden W., Minkwitz M., Ketter T., Weisler R., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry 2005; 162(7)1351–1360
- Lieberman J., Stroup T., McEvoy J., Swartz M., Rosenheck R., Perkins D., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353: 1209–1223
- McNamara D. Tip on atypicals: Track triglycerides. Clinical Psychiatry News December, 2006; 34(12)1–18
- Newcomer J. Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs 2005; 19: 1–93, (Suppl 1)
- Stahl S. Essential psychopharmacology of antipsychotics and mood stabilizers. Cambridge University Press, New York 2002
- Stahl S. Essential psychopharmacology: The prescriber's guide, Rev. ed. Cambridge University Press, New York 2005